And also we found the significant effects in terms of ADAS-Cog [Alzheimer's Disease Assessment Scale-Cognitive Subscale], ...

An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...

Galantamine slowed decline in cognitive function, functional ability, and behavior at 6 months in people with Alzheimer's ...

Together people affected by a disease that afflicts one in eight older adults in Florida, they came out to Jacksonville's ...

BEAUFORT COUNTY, N.C. (WNCT) — 1,400 beads sit in a jar, representing the number of Beaufort County residents age 65 and up ...

Researchers at Case Western Reserve school of Medicine looked at nearly one million patients in the U.S. with Type 2 diabetes ...

MONTANA - As the holiday season approaches, it is crucial to recognize the difference between stress-induced behavior changes ...

A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...

The Hispanic population has one of the highest rates of Alzheimer’s disease. While the population is growing, research is ...

TOKYO (Kyodo) -- A single course of newly approved Alzheimer's drug donanemab-azbt, the second medicine available in Japan ...

An Inverness man has described how he beat a decade of crippling anxiety to take on a double daredevil jump in aid of ...

"We are excited to have completed administering first doses to all patients enrolled in our phase 2 Alzheimer's trial,” ...